ArticleFrontiers in cardiovascular medicine2025
Integrating the BAN-ADHF diuretic resistance score into same day emergency care centres for heart failure management: a conceptual framework.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Early recognition of diuretic resistance is essential for preventing avoidable admissions and progression of acute decompensated heart failure. This Perspective synthesises current evidence and proposes a pragmatic, digitally enabled framework for embedding the Blood Urea Nitrogen, Atrial Fibrillation, N-terminal pro-B-type natriuretic peptide Acute Decompensated Heart Failure (BAN-ADHF) score into United Kingdom same-day emergency care services. Drawing on established electronic health record capabilities and the Fast Healthcare Interoperability Resources standard, we describe a three-touch-point workflow to stratify patients into low, moderate, or high-risk tiers of diuretic resistance and generate tier-specific recommendations for oral up-titration or intravenous sequential nephron blockade. Recent data demonstrating greater natriuresis without excess renal toxicity at higher score thresholds inform these protocolised actions. By integrating the automated risk stratification with tier-specific therapy, the proposed framework aims to reduce therapeutic inertia, lighten clinician workload, and align with the National Health Service mandate for digitally supported community care. Prospective evaluation is warranted to confirm clinical and economic benefits.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.